Sai Parenterals (NSE:SAIPARENT, BOM:544742) received a purchase order worth $11 million from Philippines-based PILL Corp for anti-tuberculosis products, according to an Indian bourse filing on Thursday.
Shares of the company fell nearly 2% in Friday's trade.
The agreement covers the exclusive supply of anti-tuberculosis products for the Philippines market over 10 years, with purchase orders to be released periodically during the contract term, the filing said.
The contract will be effective June 1, it added.